Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Dec 8;82(1):142–150. doi: 10.1054/bjoc.1999.0891

Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours

P A Curmi 1, C Noguès 2, S Lachkar 1, N Carelle 2, M-P Gonthier 1, A Sobel 1, R Lidereau 2, I Bièche 2
PMCID: PMC2363189  PMID: 10638981

Abstract

We recently discovered that stathmin was overexpressed in a subgroup of human breast carcinomas. Stathmin is a cytosolic phosphoprotein proposed to act as a relay integrating diverse cell signalling pathways, notably during the control of cell growth and differentiation. It may also be considered as one of the key regulators of cell division for its ability to destabilize microtubules in a phosphorylation-dependent manner. To assess the significance of stathmin overexpression in breast cancer, we evaluated the correlation of stathmin expression, quantified by reverse transcription polymerase chain reaction, with several disease parameters in a large series of human primary breast cancer (n = 133), obtained in strictly followed up women, whose clinico-pathological data were fully available. In agreement with our preliminary survey, stathmin was found overexpressed in a subgroup of tumours (22%). In addition, overexpression was correlated to the loss of steroid receptors (oestrogen, P = 0.0006; progesterone, P = 0.008), and to the Scarff–Bloom–Richardson histopathological grade III (P = 0.002), this latter being ascribable to the mitotic index component (P = 0.02). Furthermore studies at the DNA level indicated that stathmin is overexpressed irrespective of its genomic status. Our findings raise important questions concerning the causes and consequences of stathmin overexpression, and the reasons of its inability to counteract cell proliferation in the overexpression group. © 2000 Cancer Research Campaign

Keywords: human breast cancer, stathmin, quantitative RT-PCR, protein phosphorylation, prognostic factors, DNA

Full Text

The Full Text of this article is available as a PDF (108.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLOOM H. J., RICHARDSON W. W. Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer. 1957 Sep;11(3):359–377. doi: 10.1038/bjc.1957.43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Balogh A., Mège R. M., Sobel A. Growth and cell density-dependent expression of stathmin in C2 myoblasts in culture. Exp Cell Res. 1996 Apr 10;224(1):8–15. doi: 10.1006/excr.1996.0106. [DOI] [PubMed] [Google Scholar]
  3. Bargou R. C., Wagener C., Bommert K., Arnold W., Daniel P. T., Mapara M. Y., Grinstein E., Royer H. D., Dörken B. Blocking the transcription factor E2F/DP by dominant-negative mutants in a normal breast epithelial cell line efficiently inhibits apoptosis and induces tumor growth in SCID mice. J Exp Med. 1996 Mar 1;183(3):1205–1213. doi: 10.1084/jem.183.3.1205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Belmont L. D., Mitchison T. J. Identification of a protein that interacts with tubulin dimers and increases the catastrophe rate of microtubules. Cell. 1996 Feb 23;84(4):623–631. doi: 10.1016/s0092-8674(00)81037-5. [DOI] [PubMed] [Google Scholar]
  5. Beretta L., Boutterin M. C., Drouva S. V., Sobel A. Phosphorylation of a group of proteins related to the physiological, multihormonal regulations of the various cell types in the anterior pituitary gland. Endocrinology. 1989 Sep;125(3):1358–1364. doi: 10.1210/endo-125-3-1358. [DOI] [PubMed] [Google Scholar]
  6. Beretta L., Boutterin M. C., Sobel A. Phosphorylation of intracellular proteins related to the multihormonal regulation of prolactin: comparison of normal anterior pituitary cells in culture with the tumor-derived GH cell lines. Endocrinology. 1988 Jan;122(1):40–51. doi: 10.1210/endo-122-1-40. [DOI] [PubMed] [Google Scholar]
  7. Bièche I., Lachkar S., Becette V., Cifuentes-Diaz C., Sobel A., Lidereau R., Curmi P. A. Overexpression of the stathmin gene in a subset of human breast cancer. Br J Cancer. 1998 Sep;78(6):701–709. doi: 10.1038/bjc.1998.565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bièche I., Onody P., Laurendeau I., Olivi M., Vidaud D., Lidereau R., Vidaud M. Real-time reverse transcription-PCR assay for future management of ERBB2-based clinical applications. Clin Chem. 1999 Aug;45(8 Pt 1):1148–1156. [PubMed] [Google Scholar]
  9. Brattsand G., Marklund U., Nylander K., Roos G., Gullberg M. Cell-cycle-regulated phosphorylation of oncoprotein 18 on Ser16, Ser25 and Ser38. Eur J Biochem. 1994 Mar 1;220(2):359–368. doi: 10.1111/j.1432-1033.1994.tb18632.x. [DOI] [PubMed] [Google Scholar]
  10. Brattsand G., Roos G., Marklund U., Ueda H., Landberg G., Nånberg E., Sideras P., Gullberg M. Quantitative analysis of the expression and regulation of an activation-regulated phosphoprotein (oncoprotein 18) in normal and neoplastic cells. Leukemia. 1993 Apr;7(4):569–579. [PubMed] [Google Scholar]
  11. Chneiweiss H., Cordier J., Sobel A. Stathmin phosphorylation is regulated in striatal neurons by vasoactive intestinal peptide and monoamines via multiple intracellular pathways. J Neurochem. 1992 Jan;58(1):282–289. doi: 10.1111/j.1471-4159.1992.tb09308.x. [DOI] [PubMed] [Google Scholar]
  12. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  13. Cole N. B., Ellenberg J., Song J., DiEuliis D., Lippincott-Schwartz J. Retrograde transport of Golgi-localized proteins to the ER. J Cell Biol. 1998 Jan 12;140(1):1–15. doi: 10.1083/jcb.140.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Cooper H. L., McDuffie E., Braverman R. Human peripheral lymphocyte growth regulation and response to phorbol esters is linked to synthesis and phosphorylation of the cytosolic protein, prosolin. J Immunol. 1989 Aug 1;143(3):956–963. [PubMed] [Google Scholar]
  15. Curmi P. A., Andersen S. S., Lachkar S., Gavet O., Karsenti E., Knossow M., Sobel A. The stathmin/tubulin interaction in vitro. J Biol Chem. 1997 Oct 3;272(40):25029–25036. doi: 10.1074/jbc.272.40.25029. [DOI] [PubMed] [Google Scholar]
  16. Di Paolo G., Antonsson B., Kassel D., Riederer B. M., Grenningloh G. Phosphorylation regulates the microtubule-destabilizing activity of stathmin and its interaction with tubulin. FEBS Lett. 1997 Oct 20;416(2):149–152. doi: 10.1016/s0014-5793(97)01188-5. [DOI] [PubMed] [Google Scholar]
  17. Doye V., Boutterin M. C., Sobel A. Phosphorylation of stathmin and other proteins related to nerve growth factor-induced regulation of PC12 cells. J Biol Chem. 1990 Jul 15;265(20):11650–11655. [PubMed] [Google Scholar]
  18. Foley K. P., Leonard M. W., Engel J. D. Quantitation of RNA using the polymerase chain reaction. Trends Genet. 1993 Nov;9(11):380–385. doi: 10.1016/0168-9525(93)90137-7. [DOI] [PubMed] [Google Scholar]
  19. Friedrich B., Grönberg H., Landström M., Gullberg M., Bergh A. Differentiation-stage specific expression of oncoprotein 18 in human and rat prostatic adenocarcinoma. Prostate. 1995 Aug;27(2):102–109. doi: 10.1002/pros.2990270207. [DOI] [PubMed] [Google Scholar]
  20. Gavet O., Ozon S., Manceau V., Lawler S., Curmi P., Sobel A. The stathmin phosphoprotein family: intracellular localization and effects on the microtubule network. J Cell Sci. 1998 Nov;111(Pt 22):3333–3346. doi: 10.1242/jcs.111.22.3333. [DOI] [PubMed] [Google Scholar]
  21. Ghosh P. K., Anderson J., Cohen N., Takeshita K., Atweh G. F., Lebowitz P. Expression of the leukemia-associated gene, p18, in normal and malignant tissues; inactivation of expression in a patient with cleaved B cell lymphoma/leukemia. Oncogene. 1993 Oct;8(10):2869–2872. [PubMed] [Google Scholar]
  22. Hailat N., Strahler J., Melhem R., Zhu X. X., Brodeur G., Seeger R. C., Reynolds C. P., Hanash S. N-myc gene amplification in neuroblastoma is associated with altered phosphorylation of a proliferation related polypeptide (Op18). Oncogene. 1990 Nov;5(11):1615–1618. [PubMed] [Google Scholar]
  23. Han I., Kudlow J. E. Reduced O glycosylation of Sp1 is associated with increased proteasome susceptibility. Mol Cell Biol. 1997 May;17(5):2550–2558. doi: 10.1128/mcb.17.5.2550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Hanash S. M., Strahler J. R., Kuick R., Chu E. H., Nichols D. Identification of a polypeptide associated with the malignant phenotype in acute leukemia. J Biol Chem. 1988 Sep 15;263(26):12813–12815. [PubMed] [Google Scholar]
  25. Horwitz S. B., Shen H. J., He L., Dittmar P., Neef R., Chen J., Schubart U. K. The microtubule-destabilizing activity of metablastin (p19) is controlled by phosphorylation. J Biol Chem. 1997 Mar 28;272(13):8129–8132. doi: 10.1074/jbc.272.13.8129. [DOI] [PubMed] [Google Scholar]
  26. Hunt K. K., Deng J., Liu T. J., Wilson-Heiner M., Swisher S. G., Clayman G., Hung M. C. Adenovirus-mediated overexpression of the transcription factor E2F-1 induces apoptosis in human breast and ovarian carcinoma cell lines and does not require p53. Cancer Res. 1997 Nov 1;57(21):4722–4726. [PubMed] [Google Scholar]
  27. Jensen S. J., Sulman E. P., Maris J. M., Matise T. C., Vojta P. J., Barrett J. C., Brodeur G. M., White P. S. An integrated transcript map of human chromosome 1p35-p36. Genomics. 1997 May 15;42(1):126–136. doi: 10.1006/geno.1997.4714. [DOI] [PubMed] [Google Scholar]
  28. Jourdain L., Curmi P., Sobel A., Pantaloni D., Carlier M. F. Stathmin: a tubulin-sequestering protein which forms a ternary T2S complex with two tubulin molecules. Biochemistry. 1997 Sep 9;36(36):10817–10821. doi: 10.1021/bi971491b. [DOI] [PubMed] [Google Scholar]
  29. Kadonaga J. T., Carner K. R., Masiarz F. R., Tjian R. Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell. 1987 Dec 24;51(6):1079–1090. doi: 10.1016/0092-8674(87)90594-0. [DOI] [PubMed] [Google Scholar]
  30. Koppel J., Loyer P., Maucuer A., Rehák P., Manceau V., Guguen-Guillouzo C., Sobel A. Induction of stathmin expression during liver regeneration. FEBS Lett. 1993 Sep 27;331(1-2):65–70. doi: 10.1016/0014-5793(93)80298-9. [DOI] [PubMed] [Google Scholar]
  31. Larsson N., Marklund U., Gradin H. M., Brattsand G., Gullberg M. Control of microtubule dynamics by oncoprotein 18: dissection of the regulatory role of multisite phosphorylation during mitosis. Mol Cell Biol. 1997 Sep;17(9):5530–5539. doi: 10.1128/mcb.17.9.5530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Larsson N., Melander H., Marklund U., Osterman O., Gullberg M. G2/M transition requires multisite phosphorylation of oncoprotein 18 by two distinct protein kinase systems. J Biol Chem. 1995 Jun 9;270(23):14175–14183. doi: 10.1074/jbc.270.23.14175. [DOI] [PubMed] [Google Scholar]
  33. Lawler S., Gavet O., Rich T., Sobel A. Stathmin overexpression in 293 cells affects signal transduction and cell growth. FEBS Lett. 1998 Jan 2;421(1):55–60. doi: 10.1016/s0014-5793(97)01519-6. [DOI] [PubMed] [Google Scholar]
  34. Lazar V., Diez S. G., Laurent A., Giovangrandi Y., Radvanyi F., Chopin D., Bidart J. M., Bellet D., Vidaud M. Expression of human chorionic gonadotropin beta subunit genes in superficial and invasive bladder carcinomas. Cancer Res. 1995 Sep 1;55(17):3735–3738. [PubMed] [Google Scholar]
  35. Luo X. N., Mookerjee B., Ferrari A., Mistry S., Atweh G. F. Regulation of phosphoprotein p18 in leukemic cells. Cell cycle regulated phosphorylation by p34cdc2 kinase. J Biol Chem. 1994 Apr 8;269(14):10312–10318. [PubMed] [Google Scholar]
  36. Marklund U., Larsson N., Gradin H. M., Brattsand G., Gullberg M. Oncoprotein 18 is a phosphorylation-responsive regulator of microtubule dynamics. EMBO J. 1996 Oct 1;15(19):5290–5298. [PMC free article] [PubMed] [Google Scholar]
  37. Marklund U., Osterman O., Melander H., Bergh A., Gullberg M. The phenotype of a "Cdc2 kinase target site-deficient" mutant of oncoprotein 18 reveals a role of this protein in cell cycle control. J Biol Chem. 1994 Dec 2;269(48):30626–30635. [PubMed] [Google Scholar]
  38. Maucuer A., Camonis J. H., Sobel A. Stathmin interaction with a putative kinase and coiled-coil-forming protein domains. Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3100–3104. doi: 10.1073/pnas.92.8.3100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Maucuer A., Ozon S., Manceau V., Gavet O., Lawler S., Curmi P., Sobel A. KIS is a protein kinase with an RNA recognition motif. J Biol Chem. 1997 Sep 12;272(37):23151–23156. doi: 10.1074/jbc.272.37.23151. [DOI] [PubMed] [Google Scholar]
  40. Melander Gradin H., Marklund U., Larsson N., Chatila T. A., Gullberg M. Regulation of microtubule dynamics by Ca2+/calmodulin-dependent kinase IV/Gr-dependent phosphorylation of oncoprotein 18. Mol Cell Biol. 1997 Jun;17(6):3459–3467. doi: 10.1128/mcb.17.6.3459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Melhem R. F., Zhu X. X., Hailat N., Strahler J. R., Hanash S. M. Characterization of the gene for a proliferation-related phosphoprotein (oncoprotein 18) expressed in high amounts in acute leukemia. J Biol Chem. 1991 Sep 25;266(27):17747–17753. [PubMed] [Google Scholar]
  42. Nylander K., Marklund U., Brattsand G., Gullberg M., Roos G. Immunohistochemical detection of oncoprotein 18 (Op18) in malignant lymphomas. Histochem J. 1995 Feb;27(2):155–160. doi: 10.1007/BF00243911. [DOI] [PubMed] [Google Scholar]
  43. Pannetier C., Delassus S., Darche S., Saucier C., Kourilsky P. Quantitative titration of nucleic acids by enzymatic amplification reactions run to saturation. Nucleic Acids Res. 1993 Feb 11;21(3):577–583. doi: 10.1093/nar/21.3.577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Pasmantier R., Danoff A., Fleischer N., Schubart U. K. P19, a hormonally regulated phosphoprotein of peptide hormone-producing cells: secretagogue-induced phosphorylation in AtT-20 mouse pituitary tumor cells and in rat and hamster insulinoma cells. Endocrinology. 1986 Sep;119(3):1229–1238. doi: 10.1210/endo-119-3-1229. [DOI] [PubMed] [Google Scholar]
  45. Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977 Jan;35(1):1–39. doi: 10.1038/bjc.1977.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Peyron J. F., Aussel C., Ferrua B., Häring H., Fehlmann M. Phosphorylation of two cytosolic proteins. An early event of T-cell activation. Biochem J. 1989 Mar 1;258(2):505–510. doi: 10.1042/bj2580505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Pugh B. F., Tjian R. Mechanism of transcriptional activation by Sp1: evidence for coactivators. Cell. 1990 Jun 29;61(7):1187–1197. doi: 10.1016/0092-8674(90)90683-6. [DOI] [PubMed] [Google Scholar]
  48. Pugh B. F., Tjian R. Transcription from a TATA-less promoter requires a multisubunit TFIID complex. Genes Dev. 1991 Nov;5(11):1935–1945. doi: 10.1101/gad.5.11.1935. [DOI] [PubMed] [Google Scholar]
  49. Sarkar G., Bolander M. E. The "looped oligo" method for generating reference molecules for quantitative PCR. Biotechniques. 1994 Nov;17(5):864–866. [PubMed] [Google Scholar]
  50. Schubart U. K., Xu J., Fan W., Cheng G., Goldstein H., Alpini G., Shafritz D. A., Amat J. A., Farooq M., Norton W. T. Widespread differentiation stage-specific expression of the gene encoding phosphoprotein p19 (metablastin) in mammalian cells. Differentiation. 1992 Sep;51(1):21–32. doi: 10.1111/j.1432-0436.1992.tb00676.x. [DOI] [PubMed] [Google Scholar]
  51. Slamon D. J., Godolphin W., Jones L. A., Holt J. A., Wong S. G., Keith D. E., Levin W. J., Stuart S. G., Udove J., Ullrich A. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science. 1989 May 12;244(4905):707–712. doi: 10.1126/science.2470152. [DOI] [PubMed] [Google Scholar]
  52. Sobel A., Boutterin M. C., Beretta L., Chneiweiss H., Doye V., Peyro-Saint-Paul H. Intracellular substrates for extracellular signaling. Characterization of a ubiquitous, neuron-enriched phosphoprotein (stathmin). J Biol Chem. 1989 Mar 5;264(7):3765–3772. [PubMed] [Google Scholar]
  53. Sobel A. Stathmin: a relay phosphoprotein for multiple signal transduction? Trends Biochem Sci. 1991 Aug;16(8):301–305. doi: 10.1016/0968-0004(91)90123-d. [DOI] [PubMed] [Google Scholar]
  54. Sobel A., Tashjian A. H., Jr Distinct patterns of cytoplasmic protein phosphorylation related to regulation of synthesis and release of prolactin by GH cells. J Biol Chem. 1983 Sep 10;258(17):10312–10324. [PubMed] [Google Scholar]
  55. Strahler J. R., Lamb B. J., Ungar D. R., Fox D. A., Hanash S. M. Cell cycle progression is associated with distinct patterns of phosphorylation of Op18. Biochem Biophys Res Commun. 1992 May 29;185(1):197–203. doi: 10.1016/s0006-291x(05)80975-1. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES